FI943508A - Pyridinkarboximidamidföreningar och användning av dem - Google Patents

Pyridinkarboximidamidföreningar och användning av dem Download PDF

Info

Publication number
FI943508A
FI943508A FI943508A FI943508A FI943508A FI 943508 A FI943508 A FI 943508A FI 943508 A FI943508 A FI 943508A FI 943508 A FI943508 A FI 943508A FI 943508 A FI943508 A FI 943508A
Authority
FI
Finland
Prior art keywords
pyridinecarboximidamide
effect
compounds
bisalkylsulfonylamino
nitroxy
Prior art date
Application number
FI943508A
Other languages
English (en)
Finnish (fi)
Other versions
FI943508A0 (sv
FI105399B (sv
Inventor
Hideki Okawara
Tatsuo Nakajima
Nobuyuki Ogawa
Tomoko Kashiwabara
Soichiro Kaneta
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of FI943508A0 publication Critical patent/FI943508A0/sv
Publication of FI943508A publication Critical patent/FI943508A/sv
Application granted granted Critical
Publication of FI105399B publication Critical patent/FI105399B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI943508A 1992-01-28 1994-07-26 Förfarande för framställning av terapeutiskt användbara N-cyano-3-pyridinkarboxiamidinderivat FI105399B (sv)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP1334292 1992-01-28
JP1334292 1992-01-28
JP6622192 1992-03-24
JP6622192 1992-03-24
JP32576092 1992-12-04
JP32576092 1992-12-04
PCT/JP1993/000103 WO1993015057A1 (en) 1992-01-28 1993-01-28 Pyridinecarboximidamide compound and use thereof
JP9300103 1993-01-28

Publications (3)

Publication Number Publication Date
FI943508A0 FI943508A0 (sv) 1994-07-26
FI943508A true FI943508A (sv) 1994-09-22
FI105399B FI105399B (sv) 2000-08-15

Family

ID=27280214

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943508A FI105399B (sv) 1992-01-28 1994-07-26 Förfarande för framställning av terapeutiskt användbara N-cyano-3-pyridinkarboxiamidinderivat

Country Status (18)

Country Link
US (1) US5508293A (sv)
EP (1) EP0634400B1 (sv)
JP (1) JP2648395B2 (sv)
KR (1) KR100249755B1 (sv)
CN (1) CN1043760C (sv)
AT (1) ATE151073T1 (sv)
AU (1) AU674839B2 (sv)
CA (1) CA2129013C (sv)
DE (1) DE69309454T2 (sv)
DK (1) DK0634400T3 (sv)
ES (1) ES2100522T3 (sv)
FI (1) FI105399B (sv)
HK (1) HK1000094A1 (sv)
HU (1) HU218487B (sv)
MX (1) MX9300433A (sv)
NO (1) NO302070B1 (sv)
TW (1) TW232009B (sv)
WO (1) WO1993015057A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
AU6016496A (en) * 1995-06-14 1997-01-15 Sankyo Company Limited Antianginal drug comprising nitroxy derivative as active ingredient
AU5880198A (en) * 1997-02-14 1998-09-08 Kirin Beer Kabushiki Kaisha Drugs for relieving peripheral circulation disorder
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
JP2003321329A (ja) * 2002-04-25 2003-11-11 Kirin Brewery Co Ltd 育毛剤
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
JP2007525165A (ja) 2003-03-07 2007-09-06 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク タイプ１ライアノジン受容体に基づく方法
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
TW200908984A (en) * 2007-08-07 2009-03-01 Piramal Life Sciences Ltd Pyridyl derivatives, their preparation and use
EP3088390A1 (en) 2015-04-30 2016-11-02 Bayer CropScience AG Catalytic hydrogenation of substituted cyanopyridines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662567B2 (ja) * 1988-12-27 1994-08-17 麒麟麦酒株式会社 ピリジンカルボキシイミダミド誘導体、その製造中間体、製造法および用途
FI95244C (sv) * 1988-12-27 1996-01-10 Kirin Brewery Analogiförfarande för framställning av som läkemedel användbara nya karboxi-imidamidderivat eller dess farmaceutiskt lämpliga syra-additionssalter
JP2846070B2 (ja) * 1989-11-29 1999-01-13 麒麟麦酒株式会社 カルボキシイミダミド誘導体

Also Published As

Publication number Publication date
TW232009B (sv) 1994-10-11
EP0634400B1 (en) 1997-04-02
KR100249755B1 (ko) 2000-04-01
NO942740L (no) 1994-09-27
DK0634400T3 (da) 1997-04-28
EP0634400A1 (en) 1995-01-18
HU9402218D0 (en) 1994-09-28
KR950700255A (ko) 1995-01-16
EP0634400A4 (en) 1995-06-14
WO1993015057A1 (en) 1993-08-05
AU3367793A (en) 1993-09-01
ATE151073T1 (de) 1997-04-15
AU674839B2 (en) 1997-01-16
CN1043760C (zh) 1999-06-23
ES2100522T3 (es) 1997-06-16
CA2129013C (en) 2001-08-14
MX9300433A (es) 1994-07-29
DE69309454D1 (de) 1997-05-07
US5508293A (en) 1996-04-16
HUT70506A (en) 1995-10-30
JP2648395B2 (ja) 1997-08-27
HU218487B (hu) 2000-09-28
FI943508A0 (sv) 1994-07-26
FI105399B (sv) 2000-08-15
NO302070B1 (no) 1998-01-19
DE69309454T2 (de) 1997-08-14
CA2129013A1 (en) 1993-07-29
NO942740D0 (no) 1994-07-22
CN1077949A (zh) 1993-11-03
HK1000094A1 (en) 1997-11-21

Similar Documents

Publication Publication Date Title
FI943508A (sv) Pyridinkarboximidamidföreningar och användning av dem
IL148516A (en) Retroviral protease inhibiting compound
AU537414B2 (en) Pyroglutamic acid derivatives
KR900701717A (ko) 2--1,3-시클로헥산디온제초제 화합물과 이를 이용한 조성물 및 식물억제방법
ATE184605T1 (de) Methotrexat-derivate
EA199900888A1 (ru) Противоревматические средства
DK0614891T3 (da) Fremgangsmåde til fremstilling af 2-substituerede 5-chlorimidazol-4-carbaldehyder
ES2036613T3 (es) Fungicidas que contienen aminocompuestos.
GR3021821T3 (en) 5-amino-2-phenoxysulfonanilide compound.
SE8001620L (sv) Merkaptoacylderivat av ketosubstituerad prolin- och pipekolinsyra